PMC:7074432 / 4557-4841 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"178","span":{"begin":37,"end":58},"obj":"Chemical"},{"id":"182","span":{"begin":271,"end":279},"obj":"Species"},{"id":"183","span":{"begin":104,"end":118},"obj":"Disease"}],"attributes":[{"id":"A178","pred":"tao:has_database_id","subj":"178","obj":"MESH:C558899"},{"id":"A182","pred":"tao:has_database_id","subj":"182","obj":"Tax:9606"},{"id":"A183","pred":"tao:has_database_id","subj":"183","obj":"MESH:D016638"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"U bid inh) is recommended along with lopinavir + ritonavir combination.[17]\n\nImmunoglobulins\nIn case of critically ill SARS, who show signs of deterioration, further escalation of immunomodulation is indicated and intravenous (i.v.) immunoglobulin may be considered.[22] Patients who "}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T185","span":{"begin":77,"end":92},"obj":"GO:0019814"},{"id":"T184","span":{"begin":119,"end":123},"obj":"SP_10"},{"id":"T173","span":{"begin":37,"end":46},"obj":"CHEBI:6426;DG_23;CHEBI:6426"},{"id":"T172","span":{"begin":49,"end":58},"obj":"CHEBI:85129;DG_30;CHEBI:85129"}],"text":"U bid inh) is recommended along with lopinavir + ritonavir combination.[17]\n\nImmunoglobulins\nIn case of critically ill SARS, who show signs of deterioration, further escalation of immunomodulation is indicated and intravenous (i.v.) immunoglobulin may be considered.[22] Patients who "}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T6","span":{"begin":77,"end":92},"obj":"Body_part"},{"id":"T7","span":{"begin":233,"end":247},"obj":"Body_part"}],"attributes":[{"id":"A6","pred":"fma_id","subj":"T6","obj":"http://purl.org/sig/ont/fma/fma62871"},{"id":"A7","pred":"fma_id","subj":"T7","obj":"http://purl.org/sig/ont/fma/fma62871"}],"text":"U bid inh) is recommended along with lopinavir + ritonavir combination.[17]\n\nImmunoglobulins\nIn case of critically ill SARS, who show signs of deterioration, further escalation of immunomodulation is indicated and intravenous (i.v.) immunoglobulin may be considered.[22] Patients who "}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T22","span":{"begin":119,"end":123},"obj":"Disease"}],"attributes":[{"id":"A22","pred":"mondo_id","subj":"T22","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"U bid inh) is recommended along with lopinavir + ritonavir combination.[17]\n\nImmunoglobulins\nIn case of critically ill SARS, who show signs of deterioration, further escalation of immunomodulation is indicated and intravenous (i.v.) immunoglobulin may be considered.[22] Patients who "}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T21","span":{"begin":267,"end":269},"obj":"http://purl.obolibrary.org/obo/CLO_0050507"}],"text":"U bid inh) is recommended along with lopinavir + ritonavir combination.[17]\n\nImmunoglobulins\nIn case of critically ill SARS, who show signs of deterioration, further escalation of immunomodulation is indicated and intravenous (i.v.) immunoglobulin may be considered.[22] Patients who "}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T61","span":{"begin":37,"end":46},"obj":"Chemical"},{"id":"T62","span":{"begin":49,"end":58},"obj":"Chemical"}],"attributes":[{"id":"A61","pred":"chebi_id","subj":"T61","obj":"http://purl.obolibrary.org/obo/CHEBI_31781"},{"id":"A62","pred":"chebi_id","subj":"T62","obj":"http://purl.obolibrary.org/obo/CHEBI_45409"}],"text":"U bid inh) is recommended along with lopinavir + ritonavir combination.[17]\n\nImmunoglobulins\nIn case of critically ill SARS, who show signs of deterioration, further escalation of immunomodulation is indicated and intravenous (i.v.) immunoglobulin may be considered.[22] Patients who "}

{"project":"LitCovid-sentences","denotations":[{"id":"T27","span":{"begin":77,"end":92},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"U bid inh) is recommended along with lopinavir + ritonavir combination.[17]\n\nImmunoglobulins\nIn case of critically ill SARS, who show signs of deterioration, further escalation of immunomodulation is indicated and intravenous (i.v.) immunoglobulin may be considered.[22] Patients who "}

{"project":"2_test","denotations":[{"id":"32201439-32029004-47219418","span":{"begin":72,"end":74},"obj":"32029004"},{"id":"32201439-15912185-47219419","span":{"begin":267,"end":269},"obj":"15912185"},{"id":"T4398","span":{"begin":72,"end":74},"obj":"32029004"},{"id":"T78101","span":{"begin":267,"end":269},"obj":"15912185"}],"text":"U bid inh) is recommended along with lopinavir + ritonavir combination.[17]\n\nImmunoglobulins\nIn case of critically ill SARS, who show signs of deterioration, further escalation of immunomodulation is indicated and intravenous (i.v.) immunoglobulin may be considered.[22] Patients who "}